QCM
RIGL icon

Quantinno Capital Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Quantinno Capital Management’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$802K Buy
20,504
+7,537
+58% +$232K ﹤0.01% 2726
2026
Q1 		$351K Buy
12,967
+576
+5% +$19.4K ﹤0.01% 2941
2025
Q4 		$531K Buy
12,391
+1,557
+14% +$58.7K ﹤0.01% 2363
2025
Q3 		$307K Buy
+10,834
New +$324K ﹤0.01% 2435

Other funds holding RIGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quantinno Capital Management's RIGL Position: Q2 2026 in Review

Quantinno Capital Management increased its Rigel Pharmaceuticals (RIGL) stake by 58% in Q2 2026, buying an estimated $232K and bringing the position to 20,504 shares worth $802K. The position accounts for ﹤0.01% of the portfolio, ranked #2726.

Quantinno Capital Management first reported a position in RIGL in Q3 2025 and has held it in 4 quarters since. 156 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

  • Quantinno Capital Management held 20,504 shares of Rigel Pharmaceuticals worth $802K as of Q2 2026.
  • Quantinno Capital Management bought 7,537 Rigel Pharmaceuticals shares in Q2 2026, an estimated $232K.
  • Rigel Pharmaceuticals made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #2726 holding.
  • Quantinno Capital Management first reported a position in Rigel Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 156 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.